Skip to Content

Liletta Approval History

FDA Approved: Yes (First approved February 26, 2015)
Brand name: Liletta
Generic name: levonorgestrel
Dosage form: Intrauterine Device
Company: Allergan plc
Treatment for: Birth Control

Liletta (levonorgestrel) is a hormonal intrauterine device (IUD) for use by women to prevent pregnancy for up to five years.

Development History and FDA Approval Process for Liletta

DateArticle
Oct 16, 2018Approval FDA Approves Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
Aug  6, 2017Approval FDA Approves Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years
Feb 27, 2015Approval FDA Approves Liletta (levonorgestrel-releasing intrauterine system) to Prevent Pregnancy for up to Three Years
Jul 21, 2014Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for Levosert IUD

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide